approval
saveBREVIBLOC (ESMOLOL HYDROCHLORIDE) — FDA approval
community read0 votes
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalESMOLOL HYDROCHLORIDE — FDA approvalOct 22, 2025 · 355d ago
- approvalBREVIBLOC (ESMOLOL HYDROCHLORIDE) — FDA approvalJun 15, 2023 · 1215d ago
- approvalESMOLOL HYDROCHLORIDE — FDA approvalJun 8, 2018 · 3048d ago
- approvalBREVIBLOC (ESMOLOL HYDROCHLORIDE) — FDA approvalAug 14, 2015 · 4077d ago
- approvalBREVIBLOC (ESMOLOL HYDROCHLORIDE) — FDA approvalJan 26, 2015 · 4277d ago
- approvalBREVIBLOC (ESMOLOL HYDROCHLORIDE) — FDA approvalMar 20, 2014 · 4589d ago
- approvalBREVIBLOC (ESMOLOL HYDROCHLORIDE) — FDA approvalAug 13, 2013 · 4808d ago
- approvalBREVIBLOC (ESMOLOL HYDROCHLORIDE) — FDA approvalDec 11, 2012 · 5053d ago
same company · ±60 days · 6
- device recallBaxter Healthcare Corporation device recall (Cls II)Sep 17, 2025
- approvalSEVOFLURANE: SEVOFLURANE — FDA approvalOct 2, 2025
- recallBaxter Healthcare Corporation recall (Cls II)Sep 3, 2025
- device recallBaxter Healthcare Corporation device recall (Cls II)Aug 29, 2025
- device recallBaxter Healthcare Corporation device recall (Cls II)Aug 29, 2025
- device recallBaxter Healthcare Corporation device recall (Cls II)Aug 29, 2025
comments(0)
5-min edit window · permanent after that